Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cogent Biosciences, Inc. - Common Stock
(NQ:
COGT
)
39.45
-0.54 (-1.35%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cogent Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Recap: Cogent Biosciences Q1 Earnings
↗
May 09, 2023
Cogent Biosciences (NASDAQ:COGT) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023
↗
April 28, 2023
Via
Benzinga
Analyst Ratings for Cogent Biosciences
↗
April 28, 2023
Via
Benzinga
Expert Ratings for Cogent Biosciences
↗
March 27, 2023
Via
Benzinga
4 Analysts Have This to Say About Cogent Biosciences
↗
March 27, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Cogent Biosciences
↗
January 05, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
↗
December 14, 2022
Via
Benzinga
Pinterest To Rally Around 23%? Here Are 10 Other Price Target Changes For Tuesday
↗
December 13, 2022
Via
Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
↗
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via
Benzinga
Cogent Biosciences Touts Positive Data From Bezuclastinib Study In Mastocytosis Patients
↗
December 12, 2022
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
↗
August 18, 2022
Gainers
Via
Benzinga
Denbury, Global-e Online And Agilent Among Top Gainers On Wednesday
↗
August 18, 2022
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping around 170 points. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
↗
August 17, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...
Via
Benzinga
Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names
↗
July 06, 2022
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.
Via
Investor's Business Daily
Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying
↗
July 06, 2022
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022
↗
June 28, 2022
Upgrades
Via
Benzinga
89 Biggest Movers From Friday
↗
June 21, 2022
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Cboe's Weekly Market Recap: June 6th To 10th
↗
June 15, 2022
Exciting developments occurred on the Cboe Global Markets Inc. (BATS: CBOE) this week.
Via
Benzinga
91 Biggest Movers From Friday
↗
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Via
Benzinga
Mid-Afternoon Market Update: Dow Drops Over 600 Points; Fulcrum Therapeutics Shares Tumble
↗
June 10, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 600 points on Friday.
Via
Benzinga
Cogent Biosciences (COGT) Stock Soars 90% on Positive Clinical Data
↗
June 10, 2022
Today, investors in Cogent Biosciences and COGT stock have some promising clinical trial results to look at, as this stock soars.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
↗
June 10, 2022
Via
Benzinga
Why Shares Of Cogent Biosciences Are Trading Higher
↗
June 10, 2022
Cogent Biosciences, Inc. (NASDAQ: COGT) shares are trading higher after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
Via
Benzinga
Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump
↗
June 10, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling around 400 points on Friday.
Via
Benzinga
44 Stocks Moving In Friday's Mid-Day Session
↗
June 10, 2022
Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; US Inflation Rate Accelerates to 8.6%
↗
June 10, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 600 points on Friday.
Via
Benzinga
Bristol Myers Snaps Up Turning Point For $4.1 Billion In Cash — Is The Biotech Bear Dead?
↗
June 03, 2022
Bristol Myers is moving deeper into the targeted oncology space.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
↗
October 11, 2021
Upgrades According to Vertical Research, the prior rating for C.H. Robinson Worldwide Inc (NASDAQ:
Via
Benzinga
60 Biggest Movers From Yesterday
↗
August 25, 2021
Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield...
Via
Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
↗
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today